Follow The Filings

GNTX Gentex

Gentex earnings company data as of 7:59 PM ET 10/22

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 23 Oct EPS 0.52 — —
Rev — — —

Insider trades

Open-market buys and sales by GNTX's executives, directors and 10% owners in the last 12 months, from their Form 4s

All GNTX insider trades
  • None no insider bought on the open market
  • $2.8M sold by 9 insiders outside a trading plan
  • None no planned (10b5-1) sales
  1. Joseph B Anderson Jr. Director
    Sale
    $136K 5,939 shares at $22.98 100% of stake
    Traded May 15 Filed May 15
  2. Leslie L Brown Director
    Sale
    $246K 10,782 shares at $22.85 23% of stake
    Traded May 5 Filed May 5
  3. Richard O Schaum Director
    Sale
    $112K 4,815 shares at $23.31 5.6% of stake
    Traded Apr 30 Filed Apr 30
  4. Neil Boehm Chief Technology Officer
    Sale
    $279K 11,248 shares at $24.82 16% of stake
    Traded Feb 17 Filed Feb 19
  5. Matthew Chiodo Vice President of Sales
    Sale
    $496K 19,827 shares at $25.03 36% of stake
    Traded Feb 17 Filed Feb 19
  6. Scott P Ryan General Counsel
    Sale
    $223K 9,024 shares at $24.73 17% of stake
    Traded Feb 17 Filed Feb 19
  7. Steven R Downing CEO
    Sale
    $866K 35,000 shares at $24.75 14% of stake
    Traded Feb 17 Filed Feb 19
  8. Kevin C Nash CFO
    Sale
    $297K 11,885 shares at $24.98 17% of stake
    Traded Feb 17 Filed Feb 19

Also filed in the last 12 months, not counted as buying or selling: 18 stock grants, 10 share withholdings for taxes, and 3 option exercises.

SEC filings

Recent issuer filings from EDGAR, 19 shown.

Filed Form Detail Links
SCHEDULE 13G —
SCHEDULE 13G —
10-Q
8-K 2.02,9.01
8-K 5.07
10-Q
SCHEDULE 13G —
8-K 2.02,9.01
DEF 14A
DEFA14A
SCHEDULE 13G/A —
10-K
SCHEDULE 13G/A —
8-K 2.02,9.01
10-Q
8-K 2.02,9.01
SCHEDULE 13G/A —
10-Q
8-K 2.02,9.01

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.